omeprazole has been researched along with Triple Negative Breast Neoplasms in 2 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sardesai, SD | 1 |
| Thomas, A | 1 |
| Gallagher, C | 1 |
| Lynce, F | 1 |
| Ottaviano, YL | 1 |
| Ballinger, TJ | 1 |
| Schneider, BP | 1 |
| Storniolo, AM | 1 |
| Bauchle, A | 1 |
| Althouse, SK | 1 |
| Perkins, SM | 1 |
| Masters, AR | 1 |
| Stratford, RE | 1 |
| Dong, Z | 1 |
| Liu, JY | 1 |
| Zhang, JT | 1 |
| Miller, KD | 1 |
| Jin, UH | 1 |
| Lee, SO | 1 |
| Pfent, C | 1 |
| Safe, S | 1 |
1 trial available for omeprazole and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Inhibiting Fatty Acid Synthase with Omeprazole to Improve Efficacy of Neoadjuvant Chemotherapy in Patients with Operable TNBC.
Topics: Adult; Aged; Fatty Acid Synthases; Female; Humans; Middle Aged; Neoadjuvant Therapy; Omeprazole; Tre | 2021 |
1 other study available for omeprazole and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Cell Line, Tumor; Cell Movement; Cell Prolife | 2014 |